Where is Breathe Biologics based?

Breathe Biologics is based in Oceanside, United States (US).

When was Breathe Biologics founded?

Breathe Biologics was founded in 2026.

How big is Breathe Biologics?

Breathe Biologics has 2-10 employees.

Is Breathe Biologics verified on Enterprise League?

Yes — Breathe Biologics's profile is verified on Enterprise League.

Breathe Biologics

Oceanside, United States (US) · Health and Medical

We built this page from public sources. What we do with your data

Do you work at Breathe Biologics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#regenerative medicine

#biotech

#pulmonology

#ards

#copd

#lung failure

#sepsis

#pulmonary hypertension

#asthma

#emphysema

Breathe Biologics is a US-based regenerative medicine company specializing in innovative stem cell therapies for severe lung diseases, including ARDS, COPD, and pulmonary hypertension.We are dedicated to improving patient outcomes through the development of ‘JadiCell™,’ our patented umbilical cord-derived mesenchymal stem cell, a truly scalable biologic therapy.Breathe Biologics leverages a multidisciplinary team of experts in cell biology, pulmonology, and clinical development to advance our pipeline of therapies, currently focused on securing FDA approval for JadiCell in ARDS and COPD.

Overview

Breathe Biologics is a US-based regenerative medicine company specializing in innovative stem cell therapies for severe lung diseases, including ARDS, COPD, and pulmonary hypertension.

We are dedicated to improving patient outcomes through the development of ‘JadiCell™,’ our patented umbilical cord-derived mesenchymal stem cell, a truly scalable biologic therapy.

Breathe Biologics leverages a multidisciplinary team of experts in cell biology, pulmonology, and clinical development to advance our pipeline of therapies, currently focused on securing FDA approval for JadiCell in ARDS and COPD. Our commitment to rigorous clinical research and a patient-centric approach positions us as a leader in the field of regenerative medicine.

Founded in 2026, Breathe Biologics has already achieved significant milestones, including filing pivotal Phase 3 clinical trial applications for JadiCell in ARDS and initiating clinical trials for COPD. We are actively pursuing ‘Right to Try’ opportunities to provide access to our therapies for patients in need.

Visit Official Website

Most teams do this before shortlisting

Contact Details

+1407-217-3327

info@breathebiologics.com

Oceanside, United States (US), 4093 Oceanside Blvd.

+1

Founded

2026

Company Type

Private Limited Company

Employees

2-10

Keywords

#regenerative medicine

#biotech

#pulmonology

#ards

#copd

#lung failure

#sepsis

#pulmonary hypertension

#asthma

#emphysema

Awards

• 2026 OpenSee all

Products

JadiCell™

Biotechnology

JadiCell™ is a patented, allogeneic umbilical cord-derived mesenchymal stem cell therapy designed to reduce mortality and improve outcomes in patients with Acute Respiratory Distress Syndrome (ARDS), COPD, and other severe lung diseases. It’s a ‘next-generation’ therapeutic with the potential to cross the blood-brain barrier and modulate neuroinflammation.

N/A

Companies teams usually look at after Breathe Biologics

Comparing a few options usually leads to better decisions

Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.